AI assistant
CONMED Corp — Director's Dealing 2022
Mar 4, 2022
31971_dirs_2022-03-03_a2fe83a7-1492-44bf-98f5-ed1540744351.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2022-03-01
Reporting Person: KENNEDY JOHN JED (Group Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-03-01 | Common Stock | M | 1250 | — | Acquired | 8625 | Direct |
| 2022-03-01 | Common Stock | F | 394 | $144.55 | Disposed | 8231 | Direct |
| 2022-03-01 | Common Stock | M | 1250 | — | Acquired | 9481 | Direct |
| 2022-03-01 | Common Stock | F | 367 | $144.55 | Disposed | 9114 | Direct |
| 2022-03-01 | Common Stock | M | 1050 | — | Acquired | 10164 | Direct |
| 2022-03-01 | Common Stock | F | 309 | $144.55 | Disposed | 9855 | Direct |
| 2022-03-02 | Common Stock | M | 5000 | $41.93 | Acquired | 14855 | Direct |
| 2022-03-02 | Common Stock | S | 5000 | $145.50 | Disposed | 9855 | Direct |
| 2022-03-02 | Common Stock | M | 308 | $59.96 | Acquired | 10163 | Direct |
| 2022-03-02 | Common Stock | S | 308 | $145.50 | Disposed | 9855 | Direct |
| 2022-03-02 | Common Stock | M | 110 | $78.76 | Acquired | 9965 | Direct |
| 2022-03-02 | Common Stock | S | 110 | $145.50 | Disposed | 9855 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-03-01 | Rsus (restricted Stock Units) | $0 | M | 1250 | Disposed | 2029-03-01 | Common Stock (1250) | Direct |
| 2022-03-01 | Rsus (restricted Stock Units) | $0 | M | 1250 | Disposed | 2030-03-02 | Common Stock (1250) | Direct |
| 2022-03-01 | Rsus (restricted Stock Units) | $0 | M | 1050 | Disposed | 2031-03-01 | Common Stock (1050) | Direct |
| 2022-03-02 | Options To Purchase Common Stock | $41.93 | M | 5000 | Disposed | 2027-03-01 | Common Stock (5000) | Direct |
| 2022-03-02 | Options To Purchase Common Stock | $59.96 | M | 308 | Disposed | 2028-03-01 | Common Stock (308) | Direct |
| 2022-03-02 | Options To Purchase Common Stock | $78.76 | M | 110 | Disposed | 2029-03-01 | Common Stock (110) | Direct |
Footnotes
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.
F2: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
F3: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period